Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
Randomized, phase III trial of figitumumab in combination with erlotinib versus erlotinib alone in patients with nonadenocarcinoma nonsmall-cell lung cancer. [electronic resource] by
- Scagliotti, G V
- Bondarenko, I
- Blackhall, F
- Barlesi, F
- Hsia, T-C
- Jassem, J
- Milanowski, J
- Popat, S
- Sanchez-Torres, J M
- Novello, S
- Benner, R J
- Green, S
- Molpus, K
- Soria, J-C
- Shepherd, F A
Producer: 20160818
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 26
Availability: No items available.
|
|
|
17.
|
Phase I and pharmacokinetic study of BMS-184476, a taxane with greater potency and solubility than paclitaxel. [electronic resource] by
- Hidalgo, M
- Aylesworth, C
- Hammond, L A
- Britten, C D
- Weiss, G
- Stephenson, J
- Schwartz, G
- Patnaik, A
- Smith, L
- Molpus, K
- Felton, S
- Gupta, E
- Ferrante, K J
- Tortora, A
- Sonnichsen, D S
- Skillings, J
- Rowinsky, E K
Producer: 20010531
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 19
Availability: No items available.
|